16 October 2025

Precision in Cardiometabolic Biomarker Measurement

Mercodia: Cardiometabolic diseases, including diabetes, obesity, and cardiovascular conditions, are among the most pressing global health challenges.


At Mercodia, we specialize in cardiometabolic biomarker measurement, offering gold-standard immunoassays that enable researchers to generate high-quality data for drug development, clinical trials, and academic research.

Mercodia’s Immunoassays for Reliable, Actionable Data

Insulin Assays: Tailored for Every Study Design

Insulin is a cornerstone biomarker in metabolic research. Mercodia offers a range of insulin assays optimized for different sample types and study needs:

GLP-1 & GIP: Gut Hormones Driving Obesity Research

In the fight against obesity, GLP-1 and GIP are key biomarkers. These gastrointestinal peptides regulate satiety, glucose homeostasis, and energy balance, and are central to the development of next-generation weight-loss therapies.

  • GLP-1 (Total) ELISA – Chemiluminescent detection of amidated GLP-1 in human plasma and serum
  • GIP (Total) ELISA – Quantifies total GIP with no cross-reactivity to GLP-1, glucagon, or related peptides

Glucagon: A Complex Regulator of Metabolic Homeostasis

Glucagon plays a vital role in glucose regulation, especially during fasting. Its secretion is influenced by diet, disease state, and organ interactions.

  • Glucagon ELISA – High specificity, minimal matrix interference, and low sample volume requirements, ideal for studies on diabetes, obesity, and hepatic glucose production.

OxLDL: Enhancing Cardiovascular Risk Prediction

Oxidized LDL is a sensitive marker for atherosclerosis and cardiovascular disease. It is used to add predictive value beyond the traditional lipid profiles.

  • OxLDL ELISA – Targets a unique epitope in oxidized ApoB-100, enabling accurate measurement of highly oxidized LDL particles. It is used to strengthen cardiovascular risk models in both basic and clinical research.

Lp(a): A Genetic Risk Factor for Cardiovascular Disease

Lipoprotein(a), or Lp(a), is an independent and inherited risk factor for coronary and cerebrovascular disease. Elevated levels are associated with familial hypercholesterolemia and myocardial infarction.

  • Lp(a) ELISA – Quantifies Lp(a) in serum or plasma
  • Calibrated against a highly purified commercial preparation
  • Detection limit: ≤ 0.07 U/L
  • No cross-reactivity with plasminogen or ApoB

C-peptide: A Reliable Indicator of Endogenous Insulin Secretion

Mercodia’s C-peptide assays support both low-level detection and standard-range quantification, giving researchers flexibility across a wide range of study designs.

  • Ultrasensitive C-peptide ELISA
    – Detects levels below 2.5 pmol/L
    – Validated for serum, plasma, urine, and cell culture media
    – Ideal for studies in Type 1 diabetes, LADA, and transplantation
  • C-peptide ELISA
    – Designed for routine quantification of C-peptide in human samples
    – Suitable for clinical and translational research
    – Offers high specificity and minimal cross-reactivity

Why Mercodia?

At Mercodia, we go beyond providing high-quality immunoassays — we deliver a complete experience designed to support your research from start to finish.

Easy-to-Use

  • Ready-to-use calibrators
  • Color-coded reagents for intuitive handling
  • Streamlined protocols to save time and reduce error

Best-in-Class Technical Support

  • Response within 24 hours
  • Direct communication with our assay developers
  • Personalized guidance for assay selection and optimization

Long Shelf Life & Stability

  • Kits can be stored for up to 3 years
  • Stuck in customs? No problem — all kits tolerate up to 8 weeks at room temperature

Precision in Cardiometabolic Biomarker Measurement

Related articles

Newsletter for researchers

We gladly support you by keeping you updated on our latest products and the developments around our services.

we Connect you
Need help? Contact our technical support
Contact